Page 4 - Inscripta Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BOULDER — Genomic-editing platform developer Inscripta Inc. said it raised $150 million in its Series E funding round, marking yet another multi-million funding haul for biotech companies in the Boulder area. In a statement, the company said the round was co-led by Fidelity Management & Research Co. LLC and T. Rowe Price Group Inc. (Nasdaq: TROW). It brings Inscripta’s total investments from venture capital to more than $410 million since it was founded in 2015, and eclipses its $125 million Series D in late 2019. The round has not been disclosed to the U.S. Securities and Exchange Commis...

Search jobs 01-Apr-2021 Global CRISPR and CRISPR-associated (Cas) Genes Market to 2026 with Profiles of OriGene Technologies, Thermo Fisher Scientific, Takara Bio, Horizon Discovery, Addgene and More - ResearchAndMarkets.com ResearchAndMarkets.com's offering. The CRISPR and CRISPR-associated (Cas) Genes Market was estimated to be USD 1,563.52 million in 2020 and is poised to grow at a CAGR of 15.67% to reach USD 3,733.66 million by the year 2026. The COVID-19 pandemic is expected to have a positive impact on the market due to an increase in demand ...